Congratulations to CRM Sponsored Research Award 2020 winners!

The CRM Sponsored Research Award is given out each year to outstanding Principal Investigators, clinical trials sites and the industry for their contribution in sponsored research to the nation. It is given to spur and encourage more of such efforts in the future. CRM would like to honour and acknowledge their dedication in participating in sponsored research and hope that they will keep up the good work. Congratulations to all CRM Sponsored Research Award recipients:


Dr. Voon Pei Jye, from Sarawak General Hospital received the Top Recruiter award for achieving for significant patient recruitment in studies initiated in 2019.  Out of the studies initiated in 2019, he had 6 studies which achieved 1st patient enrollment within 100 days from study activation. He has also achieved the patient recruitment target in 3 of these studies.


Dr Lily Wong Lee Lee, from Queen Elizabeth Hospital received Investigator of the Year award for being Principal Investigator to the highest number of new sponsored research in 2019 (9 out of the 15 new hematology trials which was awarded in Malaysia in year 2019). She also co-authored in a global sponsored study finding which was published in high impact Blood journal in 2019


Hospital Sultan Ismail received the Clinical Trial Site of the Year award for demonstrating significant growth in the number of studies awarded in 2019. This clinical trial site had 8 studies which was initiated in 2019 compared to only 2 studies the year before, making it one of the top trial sites for oncology and dermatology studies in the country.


Merck Sharp & Dohme (MSD) received Sponsor of the Year award for contributing the highest number of new trials in 2019. MSD also brought in the highest study value in contract for that year, which contributed a total of 47.6% of the total study value recorded in 2019.


IQVIA Malaysia received CRO of the Year award for also contributing the highest number of new clinical trials in 2019. In addition, not only IQVIA did achieved the highest number of clinical trial sites initiated that year, these trial sites showed remarkable accomplishment in recruitment achievement

Malaysia an ideal site for new treatment research

PUTRAJAYA, May 20 — Malaysia has over 30 years of experience in clinical research and its various unique features makes it an ideal site to research new treatment, said Health Minister Datuk Seri Dr Adham Baba.

Among the features were ethnic diversity in population, the non-communicable diseases, experienced medical professionals, established medical infrastructures and a strong regulatory framework, he said.

“The latest being the World Health Organisation (WHO) sponsored Solidarity Trial researching several treatments for Covid-19 infection. Malaysia is the first country in Asia to enrol patients in this trial which proves our capability,” he said at the presentation of Clinical Research Malaysia (CRM) sponsored research awards in conjunction with the International Clinical Trials Day, here today.

Dr Adham said clinical trials in Malaysia were highly regulated to ensure the protection and safety of the patients as studies are required to abide to the internationally recognised standards of Good Clinical Practice.

As Malaysia moved ahead towards becoming the preferred destination for clinical research, the number of sponsored research conducted at the Health Ministry’s hospitals had also seen a healthy growth, he said.

“In 2019, a total of 162 sponsored research was reported with over 70 per cent of these studies taking place in the Health Ministry’s hospitals and health clinics.

“Most of the research are interventional trials with 66 out of 100 studies involving new treatments. A fine example is Hospital Sultan Ismail which is among the top trial sites in Malaysia for the highest growth of oncology and dermatology clinical research in 2019,” he said.

Since 2012, he said the clinical research industry had bought in a cumulative gross national income (GNI) of RM527 million in contract worth, as well as creating over 2,000 skill jobs in clinical research.

In today’s event, Dr Voon Pei Jye (medical oncologist) from Hospital Umum Sarawak received Top Recruiter Award for significant patient recruitment achievement in studies initiated in 2019.

Investigator of the Year Award presented to Dr Lily Wong Lee Lee (haematologist) from Hospital Queen Elizabeth for being principal investigator to the highest number of new sponsored research in 2019.

Hospital Sultan Ismail was recognised as the Clinical Trial Site of the Year Award for its significant growth in the number of sponsored research in 2019.

Source: Malay Mail

A Tribute to Our Heroes on International Clinical Trials Day

PUTRAJAYA, 20 May 2020 – The clinical research community in Malaysia celebrated Clinical Trials Day together with the rest of the world. This year, the celebration was done at a smaller scale to conform to social distancing and to avoid large gatherings amid the current COVID-19 outbreak. International Clinical Trials Day is celebrated around the world on May 20 every year to recognize the people who conduct clinical trials as well as the volunteers and patients who participate in it.

Clinical Trials Day has always been part of Clinical Research Malaysia’s (CRM) ongoing effort in creating awareness among the general public, patients as well as healthcare professionals that contribute to the development of better innovative treatments in the medical field.

To acknowledge the contribution of medical professionals in sponsored clinical research, a small presentation ceremony was held at the Ministry of Health complex in Putrajaya. The Minister of Health, YB Dato’ Sri Dr. Adham bin Baba, who is also the Chairman of CRM’s Board of Directors, presented the CRM Sponsored Research Award to five recipients in recognition of their significant contribution in clinical research, as well as to spur and encourage more of such efforts.

Clinicians who received the award include Dr. Voon Pei Jye (Medical Oncologist) from Hospital Umum Sarawak and Dr. Lily Wong (Haematologist) from Hospital Queen Elizabeth for contributing towards clinical trial patient recruitment and high numbers of new clinical trial uptake respectively. Hospital Sultan Ismail was recognized as the Clinical Trial Site of the Year for its significant growth in the number of sponsored research in 2019. Merck Sharp & Dohme (MSD), a multinational pharmaceutical company received Sponsor of the Year award for the highest number of new trials as well as highest cumulative study value in 2019, while IQVIA Malaysia received CRO of the Year award for the highest number of new clinical trial and trial sites initiated in 2019.

YB Dato’ Sri Dr. Adham stressed the importance of clinical trials to assess the safety and effectiveness of treatments. Malaysia has been a significant contributor in various drug and medical device clinical trials and the latest being the country’s involvement in the WHO Solidarity Trial to test several drugs in treating COVID-19. “Participation in clinical trials provides our patients with treatment options, especially those who have not responded well to the current standard of care or available treatment,” said Dr. Adham.

Communication Updates by CRM (updated 6th May 2020)




Open for Registration: Advanced GI Medical Oncology Fellowship Program by NCIS (Singapore)

The National University Cancer Institute, Singapore (NCIS) is conducting an Advanced Gastrointestinal (GI) Medical Oncology Fellowship Program.

More information on this fellowship program, please download the PDF document here.
Interested and eligible applicants can send their application to the Program Director, Dr Chee Cheng Ean.

A Milestone for Malaysia in Phase 1!

We would like to congratulate Dr. Siew-Eng Choon from Monash University for publishing a paper titled ‘Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis in the prestigious New England Journal of Medicine along side other prominent researchers.

Visit the New England Journal of Medicine website to read the paper, visit

‘I felt I could do much more than just give lectures, I could save lives’

Dr Isma Liza Mohd Isa, postdoctoral researcher at Cúram, NUI Galway. Image: NUI Galway

Dr Isma Liza Mohd Isa aims to eradicate chronic back pain forever.

A report last year found that in Ireland, back pain was the most commonly reported chronic condition, with one in five respondents to a survey saying they suffer from it.

While a multitude of different reasons could be behind back pain, ranging from diet factors to deeper bone issues, a research team is aiming to stop the problem at its source with a new hydrogel. Read more

Eid Mubarak 2017